Researcher.Life Logo

Neurodegenerative Disease Management : Impact Factor & More

eISSN: 1758-2032pISSN: 1758-2024

Key Metrics

CiteScore
3.6
H-Index
29
SJR
Q2Neurology (clinical)
SNIP
0.59
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurodegenerative Disease Management

Neurodegenerative Disease Management Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Neurodegenerative Disease Management ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurodegenerative Disease Management

Neuro-reparative potential of hyperbaric oxygen therapy in animal models of Alzheimer's and Parkinson's diseases: systematic review and meta-analysis.
  • 30 Apr 2026
  • Neurodegenerative disease management
Management of spinocerebellar ataxia.
  • 30 Apr 2026
  • Neurodegenerative disease management
Rising dementia mortality among tobacco users in the US, 2005-2020: insights from CDC-WONDER database.
  • 14 Apr 2026
  • Neurodegenerative disease management
A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.
  • 6 Apr 2026
  • Neurodegenerative disease management
Analyzing multiple-sclerosis progression: stage-specific biomarker insights via explainable machine learning.
  • 2 Apr 2026
  • Neurodegenerative disease management
Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions.
  • 1 Apr 2026
  • Neurodegenerative disease management
Neuro-reparative potential of hyperbaric oxygen therapy in animal models of Alzheimer's and Parkinson's diseases: systematic review and meta-analysis.
  • 30 Apr 2026
  • Neurodegenerative disease management
Management of spinocerebellar ataxia.
  • 30 Apr 2026
  • Neurodegenerative disease management
Rising dementia mortality among tobacco users in the US, 2005-2020: insights from CDC-WONDER database.
  • 14 Apr 2026
  • Neurodegenerative disease management
A plain language summary on clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS study.
  • 6 Apr 2026
  • Neurodegenerative disease management
Analyzing multiple-sclerosis progression: stage-specific biomarker insights via explainable machine learning.
  • 2 Apr 2026
  • Neurodegenerative disease management
Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions.
  • 1 Apr 2026
  • Neurodegenerative disease management

FAQs on Neurodegenerative Disease Management